These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mass spectrometric characterisation of a condensation product between porphobilinogen and indolyl-3-acryloylglycine in urine of patients with acute intermittent porphyria. Marcos J; Ibañez M; Ventura R; Segura J; To-Figueras J; Pozo OJ J Mass Spectrom; 2015 Jul; 50(7):929-37. PubMed ID: 26349648 [TBL] [Abstract][Full Text] [Related]
10. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Sardh E; Harper P; Andersson DE; Floderus Y Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613 [TBL] [Abstract][Full Text] [Related]
11. Brain magnetic resonance imaging white-matter lesions and cerebrospinal fluid findings in patients with acute intermittent porphyria. Bylesjö I; Brekke OL; Prytz J; Skjeflo T; Salvesen R Eur Neurol; 2004; 51(1):1-5. PubMed ID: 14631121 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria. Gomez-Gomez A; Marcos J; Aguilera P; To-Figueras J; Pozo OJ J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():347-354. PubMed ID: 28666226 [TBL] [Abstract][Full Text] [Related]
13. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria. Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865 [TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency. Collantes M; Serrano-Mendioroz I; Benito M; Molinet-Dronda F; Delgado M; Vinaixa M; Sampedro A; Enríquez de Salamanca R; Prieto E; Pozo MA; Peñuelas I; Corrales FJ; Barajas M; Fontanellas A Hum Mol Genet; 2016 Apr; 25(7):1318-27. PubMed ID: 26908609 [TBL] [Abstract][Full Text] [Related]
15. Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients. Ferrer MD; Mestre-Alfaro A; Martínez-Tomé M; Carrera-Quintanar L; Capó X; Jiménez-Monreal AM; García-Diz L; Roche E; Murcia MA; Tur JA; Pons A PLoS One; 2016; 11(10):e0164857. PubMed ID: 27788171 [TBL] [Abstract][Full Text] [Related]
16. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria. Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305 [TBL] [Abstract][Full Text] [Related]